Entrada Therapeutics Says FDA Declines To Lift Clinical Hold On ENTR-601-44 IND Application

RTTNews | vor 642 Tagen
Entrada Therapeutics Says FDA Declines To Lift Clinical Hold On ENTR-601-44 IND Application

(RTTNews) - Biopharmaceutical company Entrada Therapeutics, Inc. (TRDA) announced Wednesday the completion of dosing for the first and second cohorts of its Phase 1 clinical trial, ENTR-601-44-101.

Entrada plans to announce data from ENTR-601-44-101 in the second half of 2024.

The primary objective of Entrada's double-blind, single ascending dose Phase 1 clinical trial, which is expected to enroll approximately 40 participants, is to evaluate the safety and tolerability of a single dose of ENTR-601-44 in healthy male volunteers.

ENTR-601-44-101 will also evaluate pharmacokinetics and target engagement, as measured by exon skipping in the skeletal muscle.

Entrada was previously notified by the FDA that the IND for the Phase 1 clinical trial of ENTR-601-44 had been placed on clinical hold.

Despite providing additional information to the FDA, the Company was informed that the Agency declined to lift the clinical hold.

read more
U.S. New Home Sales Pull Back From Upwardly Revised Level In July

U.S. New Home Sales Pull Back From Upwardly Revised Level In July

New home sales in the U.S. decreased from an upwardly revised level in the month of July, according to a report released by the Commerce Department on Monday. The Commerce Department said new home sales fell by 0.6 percent to an annual rate of 652,000 in July after surging by 4.1 percent to an upwardly revised rate of 656,000 in June.
RTTNews | vor 43 Minuten
Bay Street May Open On Weak Note

Bay Street May Open On Weak Note

Canadian shares may open on a weak note Monday morning, tracking lower metal prices and European stocks. However, energy stocks may find support on higher oil prices, and help limit market's downside.
RTTNews | vor 3Std 25 Minuten
Dollar Extends Losses Amidst Powell's Dovish Surprise

Dollar Extends Losses Amidst Powell's Dovish Surprise

A markedly dovish tone in Fed Chair Jerome Powell's speech at the Jackson Hole symposium on Friday weakened the Dollar, resulting in further losses for the currency during the week ended August 22.
RTTNews | vor 4Std 10 Minuten
German Ifo Business Confidence Strongest Since 2024

German Ifo Business Confidence Strongest Since 2024

German business sentiment hit the highest level in more than two years in August on expectations that the fiscal stimulus would help to kickstart the economic recovery. The business climate index rose to 89.0 in August from 88.6 in the previous month. This was the highest score since April 2024 and also came in above economists' forecast of 88.6. The German economy's recovery remains weak.
RTTNews | vor 4Std 12 Minuten
CAC 40 Down Nearly 0.6% In Cautious Trade

CAC 40 Down Nearly 0.6% In Cautious Trade

French stocks remain in negative territory on Monday, with investors mostly making cautious moves, looking for some more clarity on U.S. - EU trade deal, and awaiting crucial inflation data from the region.
RTTNews | vor 4Std 47 Minuten
DAX Modestly Lower As Investors Wait For Directional Clues

DAX Modestly Lower As Investors Wait For Directional Clues

The German market is languishing in negative territory after a weak start on Monday as investors remain a bit reluctant to pick up stocks, choosing to wait for crucial inflation data from several major countries in Europe.
RTTNews | vor 5Std 20 Minuten
Antipodean Currencies Traded Higher Amid Risk-on Mood

Antipodean Currencies Traded Higher Amid Risk-on Mood

The antipodean currencies such as the Australia and New Zealand dollars strengthened against their major currencies in the Asian session on Monday, as Asian stock markets traded higher, on an improved outlook for interest rates after US Fed Chair Jerome Powell's dovish comments at the conference in Jackson Hole on Friday. Powell said economic risks are 'shifting' and a rate cut may be warranted.
RTTNews | vor 6Std 4 Minuten